uniquebydegrees writes: "InfoWorld is reporting about a new controversy swirling around a planned presentation at Black Hat Federal in Washington D.C. this week. Security researcher Chris Paget of IOActive will demo an RFID hacking tool that can crack HID brand door access cards. HID Corp., which makes the cards, is miffed and is accusing IOActive of patent infringement over the presentation, recalling the legal wrangling over Michael Lynn's presentation of a Cisco IOS hole at Black Hat in 2005. Black Hat's Jeff Moss says they're standing by their speaker. A news conference is scheduled for tomorrow AM. Read it here: http://www.infoworld.com/article/07/02/26/HNblackh atrfid_1.html"
sporkme writes "A scientist was frustrated when the compound she was working with (called PPAR-gamma) destroyed her sample of cancer cells. Further research revealed that the substance was surprisingly well suited as a cancer treatment. Lab test results on mice resulted in the destruction of colon tumors without making the mice sick." Quoting: "'I made a calculation error and used a lot more than I should have. And my cells died,' Schaefer said. A colleague overheard her complaining. 'The co-author on my paper said, "Did I hear you say you killed some cancer?" I said "Oh," and took a closer look.' ... [They found that the compound killed] 'pretty much every epithelial tumor cell lines we have seen.'"Update: 02/15 17:27 GMT by KD: As reader CorporalKlinger pointed out, PPAR-gamma is a cellular receptor, not a compound; and this news is not particularly new.
GillBates0 writes: "The BBC is reporting that a recent court challenge to India's patent laws by pharmaceutical giant Novartis may cut the supply of affordable medicines to treat AIDS and other epidemics in the developing world. Based on the rejection of it's patent on a drug, Novartis is arguing that India's requirement for drugs to be "new and innovative" is not in line with the WTO TRIPS (Trade Related Aspects of Intellectual Property Rights) Agreement that India is party to. India came to be called the "pharmacy of the world's poor" since it stopped issuing patents for medicines in 1970 allowing its many drug producers to create generic copies of medicines still patent-protected in other countries — at a fraction of the price charged by Western drug firms. In 2005, however, it changed it's patent laws to comply with international regulations. NGOs including Medecins Sans Frontieres (MSF) and Oxfam say that if Novartis succeeds, pharmaceutical firms will be able to put newer AIDS treatments based on existing drugs under patent protection in India, preventing cheap generic versions being exported to Africa and elsewhere. In 2005, Slashdot carried a story about efforts to put India's ancient traditional medicine and Yoga online, so as to make it visible as public domain to patent examiners. More recently, Slashdot carried a similar story about Tiwan's decision to violate Roche's patent on a bird flu drug for the benefit of it's people."
From the Blog: "There's a new bug reported in the way Firefox handles writes to the 'location.hostname' DOM property. The vulnerability could potentially allow a malicious website to manipulate the authentication cookies for a third-party site."
From what I can recollect, this seems to be the first vulnerability discovered in the actual current version of Firefox — at least for a good long time.